Abstract:ObjectivesThis study tested whether interleukin (IL)-17A is involved in the pathogenesis of mouse myocardial ischemia/reperfusion (I/R) injury and investigated the mechanisms.BackgroundInflammatory processes play a major role in myocardial I/R injury. We recently identified IL-17A as an important cytokine in inflammatory cardiovascular diseases such as atherosclerosis and viral myocarditis. However, its role in myocardial I/R injury remains unknown.MethodsThe involvement of IL-17A was assessed in functional assays in mouse myocardial I/R injury by neutralization/repletion or genetic deficiency of IL-17A, and its mechanism on cardiomyocyte apoptosis and neutrophil infiltration were further studied in vivo and in vitro.ResultsInterleukin-17A was elevated after murine left coronary artery ligation and reperfusion. Intracellular cytokine staining revealed that gamma delta T lymphocytes but not CD4(+) helper T cells were a major source of IL-17A. Anti-IL-17A monoclonal antibody treatment or IL-17A knockout markedly ameliorated I/R injury, as demonstrated by reduced infarct size, reduced cardiac troponin T levels, and improved cardiac function. This improvement was associated with a reduction in cardiomyocyte apoptosis and neutrophil infiltration. In contrast, repletion of exogenous IL-17A induced the opposite effect. In vitro study showed that IL-17A mediated cardiomyocyte apoptosis through regulating the Bax/Bcl-2 ratio, induced CXC chemokine-mediated neutrophil migration and promoted neutrophil-endothelial cell adherence through induction of endothelial cell E-selectin and inter-cellular adhesion molecule-1 expression.ConclusionsIL-17A mainly produced by gamma delta T cells plays a pathogenic role in myocardial I/R injury by inducing cardiomyocyte apoptosis and neutrophil infiltration. (J Am Coll Cardiol 2012; 59: 420-9) (C) 2012 by the American College of Cardiology Foundation

Interleukin‐17 and ischaemic stroke

Interleukin 8 (CXCL8)-CXC chemokine receptor 2 (CXCR2) axis contributes to MiR-4437-associated recruitment of granulocytes and natural killer cells in ischemic stroke.

Role of IL-17A in different stages of ischemic stroke

Interleukins and Ischemic Stroke

Interleukin-17A: the Key Cytokine in Neurodegenerative Diseases

Expanding Role of Interleukin-1 Family Cytokines in Acute Ischemic Stroke

Critical Role Of Astrocytic Interleukin-17 A In Post-Stroke Survival And Neuronal Differentiation Of Neural Precursor Cells In Adult Mice

The Role of Interleukin-17 in Mediating Joint Destruction in Rheumatoid Arthritis

Interleukin-22 Plays a Protective Role by Regulating the JAK2-STAT3 Pathway to Improve Inflammation, Oxidative Stress, and Neuronal Apoptosis following Cerebral Ischemia-Reperfusion Injury

Interleukin-17 and acute coronary syndrome

Identification of IL-17A-derived Neural Cell Type and Dynamic Changes of IL-17A in Serum/csf of Mice with Ischemic Stroke.

The role of IL-23/IL-17 axis in ischemic stroke from the perspective of gut-brain axis

Modulation of Neuroinflammation: Advances in Roles and Mechanisms of the IL-33/ST2 Axis Involved in Ischemic Stroke

IL-37 increases in patients after ischemic stroke and protects from inflammatory brain injury, motor impairment and lung infection in mice

Increased interleukin-18 level contributes to the development and severity of ischemic stroke

Interleukin-33 Ameliorates Ischemic Brain Injury in Experimental Stroke Through Promoting Th2 Response and Suppressing Th17 Response

IL-33 in Ischemic Stroke: Brain vs. Periphery

Association of Interleukin-1 Gene Cluster Polymorphisms with Ischemic Stroke in A Chinese Population

Interleukin-17A Contributes to Myocardial Ischemia/reperfusion Injury by Regulating Cardiomyocyte Apoptosis and Neutrophil Infiltration.

Exacerbation of Oxygen-Glucose Deprivation-Induced Blood-Brain Barrier Disruption: Potential Pathogenic Role of Interleukin-9 in Ischemic Stroke

Interleukin-8 and cerebral ischemia